A virtual solution to improve genetic risk evaluation for families at high risk of hereditary cancer.
A population-based virtual solution to reduce gaps in genetic risk evaluation and management in families at high risk for hereditary cancer syndromes: The Georgia-California GeneLINK Trial
['FUNDING_U01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10925218
This study is creating an easy-to-use online tool to help families understand their genetic risks for cancer, making it simpler for them to share important information and support each other, especially after someone has been diagnosed.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10925218 on ClinicalTrials.gov |
What this research studies
This research aims to enhance genetic risk evaluation (GRE) for families with identified cancer susceptibility genes by developing a virtual platform. It addresses the challenges of communication and engagement among family members regarding genetic risks, especially after a cancer diagnosis. The project will utilize innovative strategies to facilitate the sharing of genetic information and support families in understanding their risks and options for prevention. By focusing on a population-based approach, the study seeks to improve access to GRE for at-risk relatives who may be dispersed across different healthcare systems.
Who could benefit from this research
Good fit: Ideal candidates for this research are families with a history of hereditary cancer syndromes and identified pathogenic variants in cancer susceptibility genes.
Not a fit: Patients without a family history of hereditary cancer syndromes or those who do not have identified pathogenic variants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the burden of hereditary cancers by ensuring that more families receive timely and effective genetic risk evaluations.
How similar studies have performed: Previous research has shown success in using virtual platforms for genetic counseling and risk evaluation, indicating that this approach has potential for effective implementation.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KATZ, STEVEN J. — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: KATZ, STEVEN J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Burden, Cancer Patient, Cancer Susceptibility Gene, Cancer-Predisposing Gene, Cancers